Ben Jemaa et al. Journal of Experimental & Clinical Cancer Research 2010, 29:171 http://www.jeccr.com/content/29/1/171 Page 9 of 9 17. Perner S, Hofer MD, Kim R, Shah RB, Li H, Möller P, Hautmann RE, Gschwend JE, Kuefer R, Rubin MA: Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol 2007, 38:696-70. 18. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C: Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997, 3:81-85. 19. Yousef GM, Diamandis EP: The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 1992, 22:184-204. 20. Berner A, Nesland JM, Waehre H, Silde J, Fosså SD: Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens. Br J Cancer 1993, 68:380-384. 21. Lilja H, Christensson A, Dahlén U, Matikainen MT, Nilsson O, Pettersson K, Lövgren T: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991, 37:1618-1625. 22. Williams SA, Singh P, Isaacs JT, Denmeade SR: Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? Prostate 2007, 67:312-329. 23. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991, 145:907-923. 24. Stege R, Grande M, Carlström K, Tribukait B, Pousette A: Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas. Clin Cancer Res 2000, 6:160-165. 25. Arakawa A, Soh S, Chakraborty S, Scardino PT, Wheeler TM: Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 Antigen. Prostate Cancer and Prostatic Dis 1997, 1:32-38. 26. Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH: Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol 2006, 26:5310-5324. 27. Nielson GK, Sojka K, Trumbull K, Spaulding B, Welcher R: Immunohistochemical characterization of prostate specific membrane antigen expression in the vasculature of normal and neoplastic tissues. Modern Path 2004, 17:326A. 28. Laidler P, Dulińska J, Lekka M: Expression of prostate specific membrane antigen in androgen-independent prostate cancer cell line PC-3. Arch Biochem Biophys 2005, 435:1-14. 29. Moul JW: Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy. Eur Urol 1999, 35:399-407. 30. Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D, Mehes G: Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res 2009, 15:167-172. 31. Heidtmann HH, Nettelbeck DM, Mingels A, Jäger R, Welker HG, Kontermann RE: Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br J Cancer 1999, 81:1269-1273. 32. Sivridis E, Giatromanolaki A, Koukourakis MI: Tumor Angiogenesis Is Associated with MUC1 Overexpression and Loss of Prostate-specific Antigen Expression in Prostate Cancer. Clin Cancer Res 2001, 7:1533-1538. 33. Hernes E: Advanced prostate cancer. Selected aspects of human pathology, clinical oncology and epidemiology. Faculty of Medicine, Oslo 2005. 34. Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP: Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer 1998, 82:2256-2261. 35. Neves AF, Araújo TG, Biase WK, Meola J, Alcântara TM, Freitas DG, Goulart LR: Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. Clin Biochem 2008, 41:1191-1198. 36. Balk SP, Ko YJ, Bubley GJ: Biology of Prostate-specific antigen. Journal of Clinical Oncology 2003, 21:383-391. 37. Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, Poffe O, Naim HY, Heine M, Tridente G, Mainiero F, Ramarli D: The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways. Plos One 2009, 4:e4608. 38. Paliouras M, Diamandis EP: An AKT activity threshold regulates androgen- dependent and androgen-independent PSA expression in prostate cancer cell lines. Biol Chem 2008, 389:773-780. 39. Serda RE, Bisoffi M, Thompson TA, Ji M, Omdahl JL, Sillerud LO: 1alpha,25- Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells. Prostate 2008, 68:773-783. 40. Kuroda K, Liu H, Kim S, Guo M, Navarro V, Bander NH: Docetaxel down- regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy. Prostate 2009, 69:1579-1585. 41. Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT: Dissociation between androgen responsiveness for malignant growth vs expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Prostate 2003, 54:249-257. 42. Wright GL Jr, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, Moriarty R: Upregulation of prostate- specific membrane antigen after androgen-deprivation therapy. Urology 1996, 48:326-334. 43. Gustavsson H, Welén K, Damber JE: Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis. Prostate 2005, 62:364-373. 44. Tsui P, Rubenstein M, Guinan P: Correlation between PSMA and VEGF expression as markers for LNCaP tumor angiogenesis. J Biomed Biotechnol 2005, 2005:287-290. 45. Puhr M, Santer FR, Neuwirt H, Marcias G, Hobisch A, Culig Z: SOCS-3 antagonises the proliferative and migratory effects of FGF-1 2 in prostate cancer by inhibition of p44/p42 MAPK signaling. Endocr Relat Cancer 2010, 17:525-53. doi:10.1186/1756-9966-29-171 Cite this article as: Ben Jemaa et al.: Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies. Journal of Experimental & Clinical Cancer Research 2010 29:171. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit